Video
Video course abdominal ultrasound
Intrahepatic bile ducts
Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.
©2015 Falk Foundation e.V., Freiburg. All rights reserved.
Please switch on your loudspeakers!
Link to Falk Mediacenter:
http://media.falkfoundation.de/index.php?id=140&L=1
Link to the video directly:
http://media.drfalkpharma.de/fileadmin/media/24_Gall_Intrahepatic_bile_ducts_ENG.mp4
Preview images:
180 x 109 pixels
http://www.drfalkpharma.de/fileadmin/media/Video/Sono_Galle_Clip24_180P.jpg
580 x 350 pixels
http://www.drfalkpharma.de/fileadmin/media/Video/Sono_Galle_Clip24_580.jpg
Bowel
Text:
Dignass A et al, J Crohns Colitis. 2014;8(9):970–80
In mild-to-moderately active Crohn’s disease Budesonide 9 mg once daily is as effective and safe as 3 mg TID.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#28270
Text:
Kariyawasam VC et al, Inflamm Bowel Dis. 2014;20(8):1382–90
Early immunomodulator use with thiopurines or methotrexate is significantly associated with the reduced need for abdominal and perianal surgery in Crohn’s disease.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28271
Text:
Amiot A et al, Am J Gastroenterol. 2014;109(9):1443–9
In Crohn’s disease patients with enterocutaneous fistula, anti-TNF-antibody therapy may be effective in up to one third of patients, especially in the absence of stenosis and complex fistula.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28272
Liver
Biliary Tracts
Text:
Mandorfer M et al, Gastroenterology. 2014;146(7):1680–90
Patients suffering from cirrhosis and spontaneous bacterial peritonitis should not receive non-selective betablockers.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28273
Text:
Zhang H et al, Hepatology. 2014;60(2):468–76
Telbivudine and lamivudine use in late pregnancy for highly viremic mothers is equally well tolerated and effective in reducing mother-to-child transmission.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28274
Text:
Wu CY et al, Gastroenterology. 2014;147(1):143–51
In patients with chronic hepatitis B infection nucleoside analogue therapy is associated with a reduced risk of hepatocellular carcinoma.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28275
Oesophagus
Stomach
Duodenum
Text:
Li WQ et al, J Natl Cancer Inst. 2014;106(7):dju0116
Helicobacter pylori treatment can benefit older patients and those with advanced baseline histopathology, and benefits are present even with post-treatment infection, leading to a reduced risk of gastric cancer.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28276
Text:
Asher Wolf W et al, Clin Gastroenterol Hepatol. 2014;12(8):1272–9
Dietary elimination is a successful treatment modality for adults with eosinophilic esophagitis.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28277
Text:
Ko HM et al, Am J Gastroenterol. 2014;109(8):1277–85
Eosinophilic gastritis in children is highly responsive to dietary restriction therapies, implicating an allergic etiology.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28278
Pancreas
Text:
Munigala S et al, Clin Gastroenterol Hepatol. 2014;12(7):1143–50
Pancreatic adenocarcinoma must be routinely considered as a potential etiology of acute pancreatitis in patients older than 40 years of age.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20367#c28279
Current Falk literature:
NEW
The microbiota and intestinal diseases
Authors: B.J. Campbell, J.M. Rhodes
(38 pages)
S19e
Picture:
PDF:
Order by email (Please replace text by your email address):